Last 130,000 KRW
Change Today 0.00 / 0.00%
Volume 8.2K
006280 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:15 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

green cross corp (006280) Snapshot

Open
129,500
Previous Close
130,000
Day High
130,500
Day Low
128,500
52 Week High
05/3/13 - 146,191
52 Week Low
06/26/13 - 115,500
Market Cap
1.5T
Average Volume 10 Days
14.4K
EPS TTM
6,189
Shares Outstanding
11.7M
EX-Date
12/27/13
P/E TM
21.0x
Dividend
1,250
Dividend Yield
0.96%
Current Stock Chart for GREEN CROSS CORP (006280)

Related News

No related news articles were found.

green cross corp (006280) Related Businessweek News

No Related Businessweek News Found

green cross corp (006280) Details

Green Cross Corp. manufactures and sells medicine and medical supplies in South Korea. The company produces blood derivatives, including immunoglobulin, hemophilia drug, antithrombin, and tetanus immunoglobulin; develops vaccines for diseases, such as hepatitis B, influenza, epidemic hemorrhagic fever, varicella, and pandemic; and produces and sells prescription drugs for chronic diseases comprising high blood pressure, hyperlipidemia, and diabetes, as well as degenerative arthritis, musculoskeletal disorders, and fabry disease. It also produces over the counter drugs, such as anti-inflammatory analgesic drugs for external use and kids’ digestive medicines, as well as nutritional supplements and cold medicines, headache tablets, viral skin disease drugs, wound treatment drugs, placenta injections, diagnostic agents, and blood bags. Green Cross Corp. also exports its products to approximately 30 countries. The company was formerly known as Sudo Microorganism Medical Supplies Co. changed its name to Green Cross Corp. in 1971. Green Cross Corp. was founded in 1967 and is headquartered in Yongin, South Korea.

Founded in 1967

green cross corp (006280) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

green cross corp (006280) Key Developments

Green Cross Corp. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 03:00 PM

Green Cross Corp. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 03:00 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Byung-Geon Rhee, Chief Executive Officer and President.

Green Cross Corp., Annual General Meeting, Mar 15, 2013

Green Cross Corp., Annual General Meeting, Mar 15, 2013., at 10:00 Korea Standard Time. Location: Meeting-gu. Agenda: To consider the earnings results for the year ended December 31, 2012; to consider audit appointment; and to consider directors' remuneration limit.

Green Cross Corp. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-09-2013 11:30 AM

Green Cross Corp. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-09-2013 11:30 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Byung-Geon Rhee, Chief Executive Officer and President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
006280:KS 130,000.00 KRW 0.00

006280 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 006280.
View Industry Companies
 

Industry Analysis

006280

Industry Average

Valuation 006280 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GREEN CROSS CORP, please visit www.greencross.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.